SymBio Pharma USA, Inc.
Yi Shen is the Head of Strategic Planning and Global Program Management at SymBio Pharma USA, Inc. They have extensive experience in corporate strategy and operations within the pharmaceutical and biotech industries, having held leadership roles at companies such as Mirror Biologics, Luzsana Biotechnology, Cardinal Health, and more. Yi holds an MBA in Healthcare Management, Strategy, and Marketing from Columbia Business School, and a Master of Science in Separation Science/Analytical Chemistry from Brigham Young University.
This person is not in any teams
SymBio Pharma USA, Inc.
SymBio Pharma USA Inc. is the US subsidiary of SymBio Pharmaceuticals Limited, a pharmaceutical company with headquarters in Tokyo, Japan. The mission of SymBio Pharmaceuticals is to develop drugs for patients who have 'fallen through the cracks' of the pharmaceutical industry during this time of change, making drugs available to patients that would otherwise not have been developed. By adopting this patient-oriented approach, SymBio provides hope to patients in dire need of treatment through the guiding principle of mutual harmony: establishing a symbiotic relationship between patients, physicians, scientists, regulators and investors.